Wed, December 8, 2021
Tue, December 7, 2021
Mon, December 6, 2021

Vamil Divan Maintained (ACAD) at Hold with Increased Target to $26 on, Dec 7th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-26-on-dec-7th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Vamil Divan of Mizuho, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $24 to $26 on, Dec 7th, 2021.

Vamil has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Vamil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vamil


  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021